[The basic criteria for clinical evaluation of the effect of tranquilizers].
D001535:Benactyzine / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy; D002493:Central Nervous System Diseases / Q000188:drug therapy; D002707:Chlordiazepoxide / Q000627:therapeutic use; D003975:Diazepam / Q000627:therapeutic use; D004827:Epilepsy / Q000188:drug therapy; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D008620:Meprobamate / Q000627:therapeutic use; D009025:Morpholines / Q000627:therapeutic use; D009497:Neurotic Disorders / Q000188:drug therapy; D010076:Oxazepam / Q000627:therapeutic use; D011602:Psychophysiologic Disorders / Q000188:drug therapy; D011604:Psychoses, Alcoholic / Q000188:drug therapy; D011618:Psychotic Disorders / Q000188:drug therapy; D012559:Schizophrenia / Q000188:drug therapy; D014149:Tranquilizing Agents / Q000592:standards / Q000627:therapeutic use*
D009025:Morpholines; D014149:Tranquilizing Agents; D001535:Benactyzine; D010076:Oxazepam; D002707:Chlordiazepoxide; D008620:Meprobamate; D003975:Diazepam
Ob osnovnykh kriteriiakh klinicheskoĭ otsenki deĭstviia trankvilizatorov.